Xanthus Pharmaceuticals, Inc.

Quick facts

Phase 2 pipeline

• Amonafide L-Malate · Oncology
  Amonafide L-Malate is a quinazoline derivative that intercalates DNA, thereby inhibiting DNA synthesis and inducing apoptosis in cancer cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Xanthus Pharmaceuticals, Inc. portfolio CI brief
• Xanthus Pharmaceuticals, Inc. pipeline updates RSS